title: AACE Medical Guidelines for Clinical Practice for the diagnosis and treatment of acromegaly.
authors.forename: David M
authors.initials: DM
authors.lastname: Cook
authors.forename: Shereen
authors.initials: S
authors.lastname: Ezzat
authors.forename: Laurence
authors.initials: L
authors.lastname: Katznelson
authors.forename: David L
authors.initials: DL
authors.lastname: Kleinberg
authors.forename: Edward R
authors.initials: ER
authors.lastname: Laws
authors.forename: Todd B
authors.initials: TB
authors.lastname: Nippoldt
authors.forename: Brooke
authors.initials: B
authors.lastname: Swearingen
authors.forename: Mary Lee
authors.initials: ML
authors.lastname: Vance
mesh_terms: D000172:Acromegaly / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D000236:Adenoma / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D015897:Comorbidity; D018491:Dopamine Agonists / Q000627:therapeutic use; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D019635:Neurosurgical Procedures / Q000379:methods; D010911:Pituitary Neoplasms / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D011878:Radiotherapy / Q000379:methods; D011986:Receptors, Somatotropin / Q000037:antagonists & inhibitors; D013004:Somatostatin / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D018491:Dopamine Agonists; D011986:Receptors, Somatotropin; D013004:Somatostatin; D013006:Growth Hormone